Coproantibodies to the enteropathogenic Escherichia coli vaccine candidates BfpA and EspB in breastfed and artificially fed children

Vaccine

Volumn 21, Issue 15, 2003, Pages 1725-1731

  De Souza Campos Fernandes, Regina Célia ^a,b   Quintana Flores, Victor Martin ^c   Sousa de Macedo, Zila ^c   Medina Acosta, Enrique ^c  

^a Hospital Estadual Ferreira Machado   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

Author keywords

BfpA; Diarrhea; EPEC; EspB

Indexed keywords

AFFINITY PURIFIED RECOMBINANT PROTEIN; ANTIBODY; BIOLOGICAL MARKER; COPROANTIBODY; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A; PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; ARTICLE; ARTIFICIAL FEEDING; BACTERIAL INFECTION; BREAST FEEDING; CHANNEL GATING; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; FEMALE; GENE; GENE AMPLIFICATION; GENETIC STRAIN; HUMAN; IMMUNOBLOTTING; INFANT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BOTTLE FEEDING; BREAST FEEDING; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FECES; FEMALE; FIMBRIAE PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREVALENCE; VIPOMA;

EID: 0037413968     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00525-X     Document Type: Article

References (38)

1. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:1998;142-201.
2. Girón J.A., Ho A.S., Schoolnik G.K. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science. 254:1991;710-713.
3. Girón J.A., Donnenberg M.S., Martin W.C., Jarvis K.G., Kaper J.B. Distribution of the bundle-forming pilus structural gene (bfpA) among enteropathogenic Escherichia coli. J. Infect. Dis. 168:1993;1037-1041.
4. Stone K.D., Zhang H.Z., Carlson L.K., Donnenberg M.S. A cluster of fourteen genes from enteropathogenic Escherichia coli is sufficient for the biogenesis of a type IV pilus. Mol. Microbiol. 20:1996;325-337.
5. Pelayo J.S., Scaletsky I.C., Pedroso M.Z.et al. Virulence properties of atypical EPEC strains. J. Med. Microbiol. 48:1999;41-49.
6. Vieira M.A., Andrade J.R., Trabulsi L.R.et al. Phenotypic and genotypic characteristics of Escherichia coli strains of non-enteropathogenic E. coli (EPEC) serogroups that carry eae and lack the EPEC adherence factor and Shiga toxin DNA probe sequences. J. Infect. Dis. 183:2001;762-772.
7. Kaper JB, Meliies JL, Nataro JP. Pathogenicity islands and other mobile genetic elements of diarrheagenic Escherichia coli. In: Kaper JB, Hacker J, editors. Pathogenicity and other mobile virulence elements. Washington (DC): American Society for Microbiology Press; 1999. p. 33-58.
8. Cravioto A., Tello A., Villafan H., Ruiz J., del Vedovo S., Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to Hep-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J. Infect. Dis. 163:1991;1247-1255.
9. Costa-Carvalho B.T., Bertipaglia A., Sole D., Naspitz C.K., Scaletsky I.C. Detection of immunoglobulin (IgG and IgA) anti-outer-membrane proteins of enteropathogenic Escherichia coli (EPEC) in saliva, colostrum, breast milk, serum, cord blood and amniotic fluid. Study of inhibition of localized adherence of EPEC to HeLa cells. Acta Paediatr. 83:1994;870-873.
10. Camara L.M., Carbonare S.B., Scaletsky I.C., da Silva M.L., Carneiro-Sampaio M.M. Inhibition of enteropathogenic Escherichia coli (EPEC) adherence to HeLa cells by human colostrum. Detection of specific sIgA related to EPEC outer-membrane proteins. Adv. Exp. Med. Biol. 371:1995;673-976.
11. Delneri M.T., Carbonare S.B., Silva M.L., Palmeira P., Carneiro-Sampaio M.M. Inhibition of enteropathogenic Escherichia coli adhesion to Hep-2 cells by colostrum and milk from mothers delivering low-birth-weight neonates. Eur. J. Pediatr. 156:1997;493-498.
12. Manjarrez-Hernandez H.A., Gavilanes-Parra S., Chavez-Berrocal E., Navarro-Ocana A., Cravioto A. Antigen detection in enteropathogenic Escherichia coli using secretory immunoglobulin a antibodies isolated from human breast milk. Infect. Immun. 68:2000;5030-5036.
13. Loureiro I., Frankel G., Adu-Bobie J., Dougan G., Trabulsi L.R., Carneiro-Sampaio M.M. Human colostrum contains IgA antibodies reactive to enteropathogenic Escherichia coli virulence-associated proteins: intimin, BfpA, EspA, and EspB. J. Pediatr. Gastroenterol. Nutr. 27:1998;166-171.
14. Martinez M.B., Taddei C.R., Ruiz-Tagle A., Trabulsi L.R., Girón J.A. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. J. Infect. Dis. 179:1999;269-274.
15. Parissi-Crivelli A., Parissi-Crivelli J.M., Girón J.A. Recognition of enteropathogenic Escherichia coli virulence determinants by human colostrum and serum antibodies. J. Clin. Microbiol. 38:2000;2696-2700.
16. Sanches M.I., Keller R., Hartland E.L.et al. Human colostrum and serum contain antibodies reactive to the intimin-binding region of the enteropathogenic Escherichia coli translocated intimin receptor. J. Pediatr. Gastroenterol. Nutr. 30:2000;73-77.
17. Tacket C.O., Sztein M.B., Losonsky G.et al. Role of EspB in experimental human enteropathogenic Escherichia coli infection. Infect. Immun. 68:2000;3689-3695.
18. Hanson L.A. Breastfeeding provides passive and likely long-lasting active immunity. Ann. Allergy Asthma Immunol. 81:1998;523-533. [quiz 33-34, 37].
19. Schriefer A., Maltez J.R., Silva N., Stoeckle M.Y., Barral-Netto M., Riley L.W. Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live Salmonella vaccine strain. Vaccine. 17:1999;770-778.
20. da Silva J.V., Garcia A.B., Quintana Flores V.M., Sousa de Macedo Z., Medina-Acosta E. Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in transgenic tobacco and its suitability for early life vaccinologym. Vaccine. 20:2002;2091-2101.
21. Clemens J., Elyazeed R.A., Rao M. Early initiation of breastfeeding and the risk of infant diarrhea in rural Egypt. Pediatrics. 104:1999;e3.
22. Riley L.W., Junio L.N., Libaek L.B., Schoolnik G.K. Plasmid-encoded expression of lipopolysaccharide o-antigenic polysaccharide in enteropathogenic Escherichia coli. Infect. Immun. 55:1987;2052-2056.
23. Medina-Acosta E., Cross G.A. Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol. Biochem. Parasitol. 59:1993;327-329.
24. Stinear T.P., Olden D.C., Johnson P.D., Davies J.K., Grayson M.L. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet. 357:2001;855-856.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, vol. 3. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1989.
26. Quintana Flores V.M., de Souza Campos Fernandes R.C., Sousa de Macedo Z., Medina-Acosta E. Expression and purification of the recombinant enteropathogenic Escherichia coli vaccine candidates BfpA and EspB. Protein Exp. Purif. 25:2002;16-22.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354.
29. Corthesy B., Spertini F. Secretory immunoglobulin A: from mucosal protection to vaccine development. Biol. Chem. 380:1999;1251-1262.
30. Siegrist C.A. Neonatal and early life vaccinology. Vaccine. 19:2001;3331-3346.
31. Carbonare S.B., Palmeira P., Silva M.L., Carneiro-Sampaio M.M. Effect of microwave radiation, pasteurization and lyophilization on the ability of human milk to inhibit Escherichia coli adherence to Hep-2 cells. J. Diarrhoeal. Dis. Res. 14:1996;90-94.
32. Lakritz J., Tyler J.W., Hostetler D.E. Effects of pasteurization of colostrum on subsequent serum lactoferrin concentration and neutrophil superoxide production in calves. Am. J. Vet. Res. 61:2000;1021-1025.
33. Rosa A.C., Mariano A.T., Pereira A.M., Tibana A., Gomes T.A., Andrade J.R. Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil. J. Med. Microbiol. 47:1998;781-790.
34. de Andrade J.A., de Oliveira J.O., Fagundes-Neto U. Lethality in hospitalized infants with acute diarrhea: risk factors associated with death. Rev. Assoc. Med. Bras. 45:1999;121-127.
35. Palma D., Oliva C.A., Taddei J.A., Fagundes-Neto U. Acute diarrhea: stool water loss in hospitalized infants and its correlation with etiologic agents and lactose content in the diet. Arq. Gastroenterol. 34:1997;186-195.
36. Rowland M.G., Cole T.J., Tully M., Dolby J.M., Honour P. Bacteriostasis of Escherichia coli by milk. VI. The in-vitro bacteriostatic property of Gambian mothers' breast milk in relation to the in-vivo protection of their infants against diarrhoeal disease. J. Hyg. (London). 85:1980;405-413.
37. Figueroa G., Troncoso M., Araya M., Espinoza J., Brunser O. Enteropathogen carriage by healthy individuals living in an area with poor sanitation. J. Hyg. (London). 91:1983;499-507.
38. Quiroga M., Oviedo P., Chinen I.et al. Asymptomatic infections by diarrheagenic Escherichia coli in children from Misiones, Argentina, during the first twenty months of their lives. Rev. Inst. Med. Trop. (Sao Paulo). 42:2000;9-15.